baber/WOPTO huggingface dataset:
Patent NZ-555860-A (NZ)
Title: Motorised personal transport vehicle, typically motorised skateboard, with facility for yaw of front or rear tracks due to lateral movement of body weight
Inventor: BALDWIN DANIEL
IPC: A63C5/035
Filed: 2005-11-21
Abstract: The vehicle (1) includes a chassis (2) and a pair of track assemblies (3, 4) mounted at the front and rear of the chassis respectively. At least one of the track assemblies is powered by a motor (5) to propel the vehicle. The chassis include mounting points (6, 7) for attaching the track assemblies. A deck area including rider footpads (8, 9) flanks a central motor mounting section.
Patent NZ-556455-A (NZ)
Title: Improved tyre
Inventor: REWHA WILLIAM
Filed: 2007-07-11
Abstract: A tyre 2 includes a cover 6 which provides an outer surface for the tyre, two or more complementary resilient liner sections 7, 8, which together form a hoop dimensioned to be contained within the cover 6, and one or more metal reinforcing strips 10. The, or each, reinforcing strip 10 is positioned between the cover 6 and the liner sections 7, 8, around the circumference of the tyre 2. A void may be formed between the surfaces of the liner sections 7, 8 not in contact with the cover 6, and the void may be adapted to be filled with a pressurised gas in use. The outer surface of the cover 6 may be formed with a tread pattern, and each resilient liner section 7, 8 may be formed from a polymer or polymer blend.
Patent NZ-566775-A (NZ)
Title: An oculopression device
Inventor: TASKE JOHN EDWARD
IPC: A61F9/00
Filed: 2006-08-17
Abstract: An oculopression device (10) including a mass portion (21) for application of gravity assisted force onto a patient's eye; and a timer component (12) as part of the device to time the application of the mass portion to the patient's eye to prevent application for a duration sufficient to restrict ocular circulation.
Patent NZ-567244-A (NZ)
Title: Use of compositions comprising triclopyr butoxyethyl ester for the control of woody plants
Inventor: KEENEY FRANKLIN N
IPC: A01N25/02
Filed: 2006-11-17
Abstract: Disclosed is a method for controlling undesired woody vegetation which comprises applying to the foliage of the woody vegetation an herbicidal composition comprising 60 to 600 grams acid equivalent/liter triclopyr butoxyethyl ester, 25 to 150 grams/liter emulsifier and 200 to 900 grams/liter of either a dearomatized aliphatic solvent, vegetable oil or an ester of a vegetable oil as a carrier, or a water dilution of the herbicidal composition.
Patent NZ-572367-A (NZ)
Title: Fused cyclic compounds as integrase inhibitors
Inventor: CAI ZHENHONG R
IPC: C07D487/00
Filed: 2007-05-16
Abstract: Disclosed are tricyclic compounds containing at least one oxo group on a pyrrolidine ring which is fused to a bicyclic aromatic ring system as shown in formula (II) where the variables are as defined in the disclosure and it could be a benzosuccinamide. Also disclosed is a pharmaceutical composition comprising a compound of formula (II); the use of a compound of formula (II) in the manufacture of a medicament for treating the proliferation of HIV virus, treating AIDS, or delaying the onset of AIDS or ARC symptoms and a fit comprising a compound of formula (II).
Patent NZ-577973-A (NZ)
Title: Method for producing carbon black from rubber-containing waste
Inventor: BOCHAVER KIRILL ZYSKOVICH
IPC: C10B53/07
Filed: 2007-12-25
Abstract: Disclosed is a method for producing industrial carbon, hydrocarbon fuel components and raw stock for chemical industry, comprising grinding rubber-containing raw stock, separating rubber crumb from other ingredients, feeding rubber crumb into a fluidized-bed reactor, carrying out rubber crumb thermolysis in a vertical flow of a solvent being a mixture of hydrocarbons, wherein said mixture comprises alkyl aromatics, at a temperature and a pressure close to critical ones 320-350 degrees C and 4.0-6.0 MPa, and circulates through said moving fluidized bed, characterized in that said thermolysis is carried out at a solvent-waste weight ratio less than 1.0 in a reactor, said solvent performing functions of a fluidizing agent and a heat-transfer agent and a remover of reaction products from said reactor simultaneously, which ensures circulation of said solvent and full removal of all products obtained by rubber crumb thermolysis from said reactor in a common flow with said solvent.
Patent NZ-580633-A (NZ)
Title: Ergonomic and adjustable respiratory mask assembly
Inventor: MOORE RACHAEL
IPC: A62B18/02
Filed: 2003-04-17
Abstract: A respiratory mask assembly for delivering breathable gas to a patient includes a rigid frame 20 having a front surface and a rear surface adapted in use to face the patient, the frame defining rigid inner and outer walls extending from the rear surface and spaced to define a channel 26 there-between, the channel including a bottom surface defined by the frame and having a shape including a top region to engage the patient's nasal bridge, a bottom region, and two cheek regions that connect the top region and the bottom region, wherein the top region and the bottom region are generally parallel to each other. The inner wall 28 includes an inner surface facing the channel that includes at least a first protruding portion 26a that protrudes into the channel. The frame, the inner wall, the outer wall, the channel bottom and the first protruding portion are formed in one piece. The mask includes a cushion 40 that is removably attachable to the frame such that the cushion and frame are repeatably engagable with and disengagable from one another, the cushion including a flexible side wall 215 to be inserted into the channel of the frame until the side wall contacts the bottom surface of the channel and is positioned between the rigid inner and outer walls of the frame, thereby forming a sealed connection therewith. The cushion side wall has a shape that matches the shape of the channel, and an interior surface 215a that engages the first protruding portion provided on the interior surface of the inner wall of the channel when the cushion and frame are engaged with one another. Upon assembling the cushion and the frame, the interior surface and the first protruding portion engage one another to deform the side wall in the vicinity of the interior surface and provide a retaining force to help maintain the sealed connection between the cushion and the frame so that the cushion is sealed and retained relative to the frame without an additional retaining member.
Patent NZ-581127-A (NZ)
Title: Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
Inventor: GENESTE HERVE
IPC: C07D209/26
Filed: 2008-05-23
Abstract: Disclosed are compounds of formula I e.g. 1-{ 4-[(1-Methyl-1H-pyrazol-4-ylmethyl)amino]phenyl} butan-1-one wherein the substituents are defined in the specification for treating migraines, schizophrenia, epilepsy, symptoms associated with substance related disorders and anxiety.
Patent NZ-589529-A (NZ)
Title: Brake system, generator and wind turbine
Inventor: ERIKSEN UFFE
IPC: H02K7/102
Filed: 2010-11-25
Abstract: A brake system, especially for a generator (6), comprising a rotor assembly (8), a stator assembly (7) and a rotation axis (9) is disclosed. The rotor assembly (8) comprises an outer portion (11) which is located radially outward of the stator assembly (7). The outer portion (11) comprises a brake disc (12), and the stator assembly (7) comprises at least one frictional member (13) operatively configured for frictionally engaging at least a portion of the brake disc (12).
Patent NZ-589855-A (NZ)
Title: Appliance with two washing modes with separate temperatures and sub-program steps including preliminary rinse, final rinse and dry which are carried out at temperatures less than the washing mode temperatures
Inventor: JERG HELMUT
IPC: A47L15/00
Filed: 2009-07-15
Abstract: Disclosed is a washing method for a water-conveying domestic appliance, in particular a dishwasher which has a drying device having a reversibly dehydratable desiccant. In at least one sub-program step (?tH) of a first washing operation washing liquid is warmed up in a first mode of operating (I) to a first temperature (TR1). A prescribed number of washing operations is carried out in the first mode of operation (I) and/or as a function of process parameters of preceding washing operations. At least one washing operation is carried out in a second mode of operation (II), during which washing liquid is warmed up to a second temperature (TR2) which is higher by comparison with the first temperature (TR1). The at least one sub-program step (Z, K, T), which can be carried out in the first or second mode of operation (I, II), is a cleaning step in which the first and second temperatures (TR1, TR2) respectively correspond to a cleaning temperature. The temperatures of sub-program steps preliminary rinse (Z), final rinse (K) and dry (T) which are carried out after the cleaning step, are less than the first or second cleaning temperature (TR1, TR2).
Patent NZ-591883-A (NZ)
Title: Plastic inspection chamber
Inventor: CLAY CHRIS
IPC: E03F5/02
Filed: 2011-03-23
Abstract: A plastic access chamber 10 comprising a unitary body portion 11 with a base and at least one wall extending from the base. The body portion 11 is configured to receive a removable lid 12 such that a watertight seal is created between the lid 12 and the top of the at least one wall of the body portion 11. The access chamber 10 has a volume of substantially 0.2m3 and a height of at least substantially 600mm.
Patent NZ-596162-A (NZ)
Title: Pharmaceutical composition for the treatment of heart diseases
Inventor: GAUSSIN VINCIANE
IPC: A61K35/34
Filed: 2010-05-20
Abstract: Discloses composition including mammalian cells committed to the generation of heart tissue, wherein said cells show: i. an observed increase in expression level as compared to a reference of MEF2C and optionally at least one gene further selected from the group consisting of Nkx2.5, Tbx5, GATA4, GATA6, Mesp1, FOG1 FOG2, Flk1; and/or ii. an observed presence of at least one polypeptide species chosen from the group consisting of Nkx2.5, Tbx5, GATA4, GATA6, Mesp1, FOG1 FOG2, Flk1, as compared to a reference and nuclear translocation to the nuclei of the cell of one or more of Nkx2.5 and MEF2C; and at least one pharmaceutically acceptable excipient, wherein the excipient includes at least dimethylsulfoxide (DMSO).
Patent NZ-600881-A (NZ)
Title: Pyrazole derivatives as jak inhibitors
Inventor: BACH TANA JORDI
IPC: C07D487/04
Filed: 2011-02-18
Abstract: Disclosed herein is a pyrazole derivative compound of general formula (I), wherein the subsittuents are defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as JAK inhibitors, as such is useful in the treatment of a pathological condition or disease selected from myeloproliferative disorders, leukemia, lymphoid malignancies and solid tumors; bone marrow and organ transplant rejection; and immune-mediated diseases, or wherein the pathological condition or disease is selected from inflammatory diseases. Compounds of the invention include: 3-(4-{ [(1S)-2-Methoxy-1-methylethyl]amino} pyrimidin-2-yl)pyrazolo[1,5-a]pyridine-5-carbonitrile, 3-{ 4-[(2,2,2-Trifluoroethyl)amino]pyrimidin-2-yl} pyrazolo[1,5-a]pyridine-5-carbonitrile and 3-(4-{ [(3R)-1-(Cyanoacetyl)piperidin-3-yl]amino} pyrimidin-2-yl)pyrazolo[1,5-a]pyridine-5-carbonitrile
Patent NZ-603105-A (NZ)
Title: Detection of mutations in a gene associated with resistance to viral infection, oasi
Inventor: GUILLAUDEUX THIERRY
IPC: C07H21/04
Filed: 2004-10-22
Abstract: Disclosed is an isolated polypeptide consisting of an amino acid sequence having at least 98% identity to SEQ ID NO: 48, wherein the variable amino acid positions of SEQ ID NO: 48 consist of at least one of Asn at position 31, Phe at position 115, Gly at position 127, Gly at position 162, Asn at position 280, and Pro at position 330; wherein the SEQ ID is as disclosed in the specification. Also disclosed are methods of producing the said polypeptide, and the use of the polypeptide in the manufacture of a medicament for treating viral infection in a mammal wherein said polypeptide comprises oligoadenylate synthetase 1 (OAS1).
Patent NZ-606441-A (NZ)
Title: Biomarkers for the diagnosis and/or prediction of susceptibility to mental and neurodegenerative disorders
Inventor: FRYAR-WILLIAMS STEPHANIE
IPC: G01N33/50
Filed: 2009-12-09
Abstract: Disclosed is a method for predicting the susceptibility of a subject to a mental or neurodegenerative disorder, the method comprising determining the levels of two biomarkers in one or more biological samples derived from a subject, wherein the biomarkers are hydroxyhemopyrrolene-2-one (HPL) and homocysteine.
Patent NZ-606643-A (NZ)
Title: Systems for purging polyethylene terephthalate from an extrusion blow molding apparatus
Inventor: HIMES KEVIN D
IPC: B29C49/04
Filed: 2011-08-25
Abstract: Disclosed is a system for purging molten thermoplastic material from a molding apparatus. The purge system includes a blow mold apparatus (see figure 5) and a purge diverter valve (10) operably connected to the blow mold apparatus. The purge diverter valve has a channel (18), a closing member (24), and a spacer (30) having a conduit (32) in communication with the channel (18). A melt pipe (see 110, figure 5) is further in communication with the channel (18) via a branch (16) extending off the channel. When the closing member is in the closed position (see 24, dashed lines) the valve channel is plugged, preventing molten thermoplastic material from the conduit entering the valve. When the closing member is in the open position (see 24, solid lines) molten thermoplastic material is able to flow from the conduit, through the channel, then via the branch to the melt pipe, to divert the molten thermoplastic material away. A head tooling pin (38) is coordinated with the closing member (24) such that when the closing member (24) is open (as in figure 2), the head tooling pin (38) is closed, plugging the conduit (32) and diverting substantially all of the molten thermoplastic material into the valve channel (18). The head tooling pin (38) is further coordinated with the closing member (24) such that when the closing member (24) is closed (as in figure 5) the head tooling pin (38) is open, allowing the molten thermoplastic material to flow through the conduit (32).
Patent NZ-612544-A (NZ)
Title: Heterocyclic compounds suitable for the treatment of dyslipidemia
Inventor: PINGALI HARIKISHORE
IPC: C07D413/12
Filed: 2011-12-26
Abstract: The disclosure relates compounds of general formula (I), wherein A, Y, Z, X, W, R1, R2, R3 and n are as described in the specification, their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation. The compounds may be used to treat hyperlipidaemia, dyslipidaemia and other similar diseases. Examples of these compounds include: N-((tetrahydro-2H-pyran-4-yl)methyl)-2-((5-(1-(((4-(trifluoromethyl)benzyl)oxy)imino)propyl)pyridin-2-yl)oxy)acetamide; N-((tetrahydro-2H-pyran-4-yl)methyl)-2-((5-(1-(((4-(trifluoromethyl)benzyl)oxy)imino)propyl)pyridin-2-yl)amino)acetamide; 2-((5-(1-((benzyloxy)imino)propyl)pyridin-2-yl)oxy)-N-((tetrahydro-2H-pyran-4-yl)methyl)acetamide; 2-((5-(1-(((4-methylbenzyl)oxy)imino)propyI)pyridin-2-yl)oxy)-N-((tetrahydro-2Hpyran-4-yl)methyl)acetamide; 2-((5-(1-(((4-methoxybenzyl)oxy)imino)propyl)pyridin-2-yl)oxy)-N-((tetrahydro-2H-pyran-4-yl)methyl)acetamide; N-((tetrahydro-2H-pyran-4-yl)methyl)-2-((5-(1-(((4-(trifluoromethyl)benzyl)oxy)imino)ethyl)pyridin-2-yl)oxy)acetamide; N-((tetrahydro-2H-pyran-4-yl)methyl)-2-((5-(1-(((4-(trifluoromethyl)benzyl)oxy)imino)ethyl)pyridin-2-yl)amino)acetamide; N-((tetrahydro-2H-pyran-4-yl)methyl)-2-((4-(1-(((4-(trifluoromethyl)benzyl)oxy)imino)propyl)phenyl)amino)acetamide; 2,2’-((5-(1-(((4-(trifluoromethyl)benzyl)oxy)imino)ethyl)oxazol-2-yl)azanediyl)bis(N-((tetrahydro-2H-pyran-4-yl)methyl)acetamide).
Patent NZ-616761-A (NZ)
Title: Amino acid sequences directed against il-17a, il-17f and/or il17-a/f and polypeptides comprising the same
Inventor: ROMMELAERE HEIDI
IPC: C07K16/46
Filed: 2012-05-04
Abstract: Discloses a polypeptide comprising (i) a first amino acid sequence comprising at least one immunoglobulin single variable domain (ISV), which specifically binds to IL-17F (SEQ ID NO: 840) and to a heterodimer of IL-17A (SEQ ID NO: 839) and IL-17F (SEQ ID NO: 840) but does not specifically bind to IL-17A (SEQ ID NO: 839); and (ii) a second amino acid sequence comprising at least one immunoglobulin single variable domain (ISV), which specifically binds to IL-17A (SEQ ID NO: 839), to IL-17F (SEQ ID NO: 840) and to a heterodimer of IL-17A (SEQ ID NO: 839) and IL-17F (SEQ ID NO: 840), wherein the sequences are as defined in the complete specification.
Patent NZ-623752-A (NZ)
Title: Methods and devices for drug delivery to ocular tissue using microneedle
Inventor: PATEL SAMIRKUMAR RAJNIKANT
IPC: A61M5/31
Filed: 2011-04-26
Abstract: Disclosed is the use of a fluid drug formulation in the manufacture of a medicament for the treatment of an ocular disease selected from uveitis, glaucoma, diabetic macular edema, diabetic retinopathy, macular degeneration, choroidal neovascularization or cytomegalovirus retinitis, wherein the medicament is formulated to be delivered via a hollow microneedle, the microneedle having a beveled tip end with an opening, wherein the medicament is formulated for being infused over a period of time through the inserted microneedle and into the suprachoroidal space of the eye, wherein the medicament is formulated to flow posterior to the equator of the eye during the infusion period.
Patent NZ-627480-A (NZ)
Title: Inhibitors of iap
Inventor: COHEN FREDERICK
IPC: C07D417/14
Filed: 2013-01-03
Abstract: Substituted phenyl-thiazole-oxazolyl compounds of formula (I) are disclosed, wherein the variables R1, R2, R3, R4, R5 and R6 are as described in the specification. These compounds are capable of inducing apoptosis in a cell and are suitable for inhibiting the binding of an IAP protein to a caspase protein and are useful for treating a disease or condition such as cancer malignancies which are associated with the overexpression of an IAP.
Patent NZ-726208-A (NZ)
Title: Deuterated heterocyclic compounds and their use as imaging agents
Inventor: LYSSIKATOS JOSEPH P
IPC: C07D401/04
Filed: 2015-05-12
Abstract: The present invention relates to deuterated and optionally detectably labeled compounds and salts thereof. Also included are pharmaceutical compositions comprising such compounds and salts, and methods of using such compounds and salts as imaging agents, in particular in measuring the radioactive signal of the compound associated with amyloid deposits and/or tau protein aggregates.
Patent NZ-730873-A (NZ)
Title: Apparatus and process for packaging a product
Inventor: RIZZI JVANOHE
IPC: B29C65/22
Filed: 2015-10-08
Abstract: A process for packaging a product (P) arranged on a support (4) comprising unrolling a film (18), moving the film (18) to a packaging assembly (8) defining at its inside a packaging chamber (24), progressively moving a number of supports (4) inside the packaging chamber (24) of the packaging assembly (8), closing the packaging chamber (24) with the film sheets held above the respective support (4), optionally causing one or both of: a gas withdrawal from the hermetically closed packaging chamber (24) and gas injection of a gas mixture of controlled composition, heat sealing the film (18) to said support (4), wherein the heat sealing uses one or more heaters having heating surfaces which are heated for discrete and short time periods only. An apparatus (1) for performing the above process is also disclosed.
Patent NZ-737340-A (NZ)
Title: Disposable infusion fluid delivery device for programmable large volume drug delivery
Inventor: SHUBINSKY GARY DAVID
IPC: G16H20/17
Filed: 2016-05-16
Abstract: A disposable electronically controlled infusion pump system includes a non-disposable microcontroller; a disposable infusion container and a plurality of disposable electronically controlled medication pumping systems. The disposable infusion container is configured to contain infusion fluid. The = disposable electronically controlled medication pumping systems are fluidly connected to the disposable infusion container. Each of the disposable electronically controlled medication pumping systems includes an infusion channel, a disposable electronically controlled micropump, and valves, but may further include a microprocessor, a memory, a battery or power receiver configured to wirelessly receive power, a wireless communication device, and other components. The memory is in electronic communication with the microprocessor. The wireless communication device is configured to receive a wireless signal which wirelessly controls the plurality of disposable electronically controlled medication pumping systems. The disposable electronically controlled micropump is configured to pump the infusion fluid through the infusion channel. The valves are connected to the infusion channel. The non-disposable microcontroller is configured to wirelessly control the plurality of disposable electronically controlled medication pumping systems. This disclosure relates to a disposable electronically controlled infusion pump system configured for large volume drug delivery. This system is designed to be used only once for a particular patient, and then disposed of.
Patent NZ-746044-A (NZ)
Title: Ultra-compact profile actuation system for an adjustable bed
Inventor: TOTEMEIER HUNTER
IPC: A61G7/015
Filed: 2017-02-08
Abstract: An articulating bed incorporates a support frame (10) with a head end, a foot end and having side frame members. A carriage (12) having a seat support is carried by the frame, mounted with wheels engaging the side frame members to translate from a first position through a range progressing toward the head end to a fully translated position. An upper body support (16) is rotatably connected to the carriage and carries a mattress support (15). At least one telescoping rotation strut (18) is attached at a first end and rotates through an axle (19) pivotally attached to the side frame members. The telescoping rotation strut engages at a second end the upper body support. At least one fixed length rotation arm is carried at a first end by a rotating tube (22) and pivotally attaches to the upper body support at a second end. The rotating tube is mounted on wheels constrained in a track and translates laterally in the track to contact a track end proximate the head end of the frame at a termination of a first range of motion. The telescoping strut approaches a vertical orientation and transfers reaction forces resulting from translation of the carriage to the fixed length rotation arm, whereupon the telescoping rotations struts extend.
Patent NZ-747496-A (NZ)
Title: Mask system
Inventor: ROMAGNOLI JOSE
IPC: A61M16/06
Filed: 2011-09-30
Abstract: Disclosed is a ventilation mask system for delivery of gaseous or air respiratory therapy such as CPAP to a patient, comprising a frame; a nares portion having a pair of nozzles, a nose tip engagement portion that engages and seals with the patient’s nose tip and an attachment ring. The attachment ring is adapted to removably attach the nares portion to the frame via a snap-fit connection; a headgear assembly that is designed to removably attach to the frame and retain the mask system in position on the head of the patient; and an elbow having a vent portion configured to vent expired air, and wherein the elbow is attached to the frame via a ball and socket arrangement.